These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27007611)

  • 1. Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.
    Geyer R; Nordemann U; Strasser A; Wittmann HJ; Buschauer A
    J Med Chem; 2016 Apr; 59(7):3452-70. PubMed ID: 27007611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
    Igel P; Geyer R; Strasser A; Dove S; Seifert R; Buschauer A
    J Med Chem; 2009 Oct; 52(20):6297-313. PubMed ID: 19791743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
    Geyer R; Kaske M; Baumeister P; Buschauer A
    Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for histamine H4 receptor in human monocytes.
    Werner K; Neumann D; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2014 Dec; 351(3):519-26. PubMed ID: 25273276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
    Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and histamine H(3) and H(4) receptor activity of conformationally restricted cyanoguanidines related to UR-PI376.
    Geyer R; Buschauer A
    Arch Pharm (Weinheim); 2011 Dec; 344(12):775-85. PubMed ID: 21987304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimeric carbamoylguanidine-type histamine H2 receptor ligands: A new class of potent and selective agonists.
    Kagermeier N; Werner K; Keller M; Baumeister P; Bernhardt G; Seifert R; Buschauer A
    Bioorg Med Chem; 2015 Jul; 23(14):3957-69. PubMed ID: 25639885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking and MD study of histamine H4R based on the crystal structure of H1R.
    Feng Z; Hou T; Li Y
    J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
    Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
    Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.
    Ghorai P; Kraus A; Keller M; Götte C; Igel P; Schneider E; Schnell D; Bernhardt G; Dove S; Zabel M; Elz S; Seifert R; Buschauer A
    J Med Chem; 2008 Nov; 51(22):7193-204. PubMed ID: 18950149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.
    Kazuta Y; Hirano K; Natsume K; Yamada S; Kimura R; Matsumoto S; Furuichi K; Matsuda A; Shuto S
    J Med Chem; 2003 May; 46(10):1980-8. PubMed ID: 12723960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tritium-labeled N(1)-[3-(1H-imidazol-4-yl)propyl]-N(2)-propionylguanidine ([(3)H]UR-PI294), a high-affinity histamine H(3) and H(4) receptor radioligand.
    Igel P; Schnell D; Bernhardt G; Seifert R; Buschauer A
    ChemMedChem; 2009 Feb; 4(2):225-31. PubMed ID: 19101971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
    Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Dynamic, Split-Luciferase-Based Mini-G Protein Sensor to Functionally Characterize Ligands at All Four Histamine Receptor Subtypes.
    Höring C; Seibel U; Tropmann K; Grätz L; Mönnich D; Pitzl S; Bernhardt G; Pockes S; Strasser A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.
    Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
    Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist.
    Lim HD; Smits RA; Bakker RA; van Dam CM; de Esch IJ; Leurs R
    J Med Chem; 2006 Nov; 49(23):6650-1. PubMed ID: 17154494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.
    Igel P; Schneider E; Schnell D; Elz S; Seifert R; Buschauer A
    J Med Chem; 2009 Apr; 52(8):2623-7. PubMed ID: 19317445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.
    Smits RA; Lim HD; Stegink B; Bakker RA; de Esch IJ; Leurs R
    J Med Chem; 2006 Jul; 49(15):4512-6. PubMed ID: 16854056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine.
    Hashimoto T; Harusawa S; Araki L; Zuiderveld OP; Smit MJ; Imazu T; Takashima S; Yamamoto Y; Sakamoto Y; Kurihara T; Leurs R; Bakker RA; Yamatodani A
    J Med Chem; 2003 Jul; 46(14):3162-5. PubMed ID: 12825954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.